Welcome to the official website of the Ethypharm Group. This website is regulated by the Code of Best Practices of the International Federation of Pharmaceutical Manufacturers. Some information on this site may not be in conformity with French regulations on advertising. By continuing your navigation, you accept this website's use of cookies.

About Us

Ethypharm is a European-based speciality pharmaceutical company with global reach and is a committed player in the treatment of pain, addiction and critical care.

Ethypharm develops, manufactures and supplies cost effective complex medicines that allows better access to medicines for patients across the world.

We have a clear pathway

Our ambition is to grow our own commercial structures in Europe and to accelerate our global expansion through strong and sustainable partnerships. We are actively seeking new value-adding products in our fields of expertise.

We are closer than ever to the patients

We have a strong presence and expertise in marketing hospital and speciality medicines and we are recognised as a key strategic partner and a trusted provider of quality and affordable medicines to the NHS and other healthcare providers.

Focusing on the treatment of pain, addiction and critical care, Ethypharm in the UK develops, manufactures and commercialises value-adding drugs at our two manufacturing sites that specialise in the development and production of sterile injectables and oral liquids.

A stronger company in the UK

In 2017 Ethypharm Group acquired Martindale Pharma, a leading UK based specialty pharmaceutical company which provides essential medicines to the UK and other global markets. By joining forces with Martindale Pharma, Ethypharm reinforced its presence in the UK. The combined business reaches a broader geographical footprint and enhances manufacturing capabilities to include solid dose, injectables and oral liquids.

By clicking on this link, you agree to leave our website.
Are you sure?

NO     YES
Picto_Information FREQUENTLY ASKED QUESTIONS Fermer
select products
PRODUCTSREQUESTS
Abtard®
  • Are there bioequivalence data with OxyContin? Fleche bas
  • Yes, data from twelve bioequivalence studies comparing Abtard with the reference product were submitted in support of the application for Marketing Authorisation.
  • How do I store Abtard® tablets? Fleche bas
  • We do not have information on the stability of Abtard® tablets outside of the original packaging. Abtard® tablets must be stored below 25°C in the original packaging to protect from moisture.
  • Is Abtard Monophasic or biphasic? Fleche bas
  • Abtard prolonged -release tablets are bioequivalent to OxyContin prolonged-release tablets and are biphasic, meaning that there is an initial absorption of approximately 40% of oxycodone from the tablet providing onset of analgesia within one hour in most patients, followed by a more controlled absorption, which determines the 12-hour duration or action.
  • How do I take Abtard® tablets? Fleche bas
  • Abtard® tablets must be taken as directed by your doctor or pharmacist. Abtard® tablets must be swallowed whole with a sufficient amount of liquid and not chewed.
  • Are the tablets film coated? Fleche bas
  • Yes they are
  • Are 2 x 60mg tablets bioequivalent to a single 120mg strength of OxyContin? Fleche bas
  • There are no bioequivalence studies for Abtard 2 x 60mg versus one single dose of 120mg of OxyContin.  It is a matter of clinical judgement for the prescriber to decide whether 2 x 60 mg tablets can be used.  What the bioequivalence studies prove is that Abtard 60mg is bioequivalent to OxyContin 60mg.  In practice if a retail pharmacist received a prescription for 120mg of OxyContin and only had the 60mg OxyContin available would they give 2 x 60mg tablets
DIDN'T FIND WHAT YOU WERE LOOKING FOR?
Please feel free to contact us for any further question. Please note that we are unable to provide medical advice.
Contact: medinfo@martindalepharma.co.uk
Picto_Calculette HOW MUCH COULD YOU SAVE ? Fermer
CHOOSE YOUR CCG
TOTAL CCG
SAVINGS
across our products
£0.00
CHOOSE A PRACTICE NAME
TOTAL PRACTICE
SAVINGS
across our products
£0.00

England & Wales
The data in this dashboard includes General Practice Prescribing Data - NHS prescriptions that are prescribed in England & Wales by GPs, and non medical prescribers that have prescribed on behalf of the GP practice, that are then dispensed in the community.

NHS Prescription Services, part of the NHS Business Services Authority (BSA), is the provider of the England data and NHS Wales Shared Partnerships Services is the provider of the Wales data.

This public sector information is licensed under the Open Government Licence v3.0.

The cost model compares Ethypharm products to alternative products. Only comparable doses of alternative products, which can be clearly identified in the NHS prescription data, are used in the model.

Scotland
The data in this dashboard includes General Practice Prescribing Data - NHS prescriptions that are prescribed in Scotland by GPs, and non medical prescribers that have prescribed on behalf of the GP practice, that are then dispensed in the community.

ISD, NHS Scotland is the provider of the data.

This public sector information is licensed under the Open Government Licence v3.0.

The cost model compares Ethypharm products to alternative products. Only comparable doses of alternative products, which can be clearly identified in the NHS prescription data, are used in the model.